Janus Henderson Investors US’s Agios Pharmaceuticals AGIO Stock Holding History

Janus Henderson Investors US’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$21.9M	Sell	375,084 -9,180	-2%	-$440K	0.02%	595
2016 Q4	$16M	Buy	384,264 +45,509	+13%	+$2.39M	0.01%	657
2016 Q3	$17.9M	Buy	+338,755	New	+$14.8M	0.02%	611
2016 Q2	–	Sell	-95,501	Closed	-$3.88M	–	1189
2016 Q1	$3.88M	Sell	95,501 -2,302	-2%	-$98.4K	﹤0.01%	806
2015 Q4	$6.35M	Buy	97,803 +2,560	+3%	+$168K	0.01%	783
2015 Q3	$6.72M	Sell	95,243 -205,527	-68%	-$20.1M	0.01%	783
2015 Q2	$33.4M	Buy	300,770 +10,565	+4%	+$1.14M	0.03%	507
2015 Q1	$27.4M	Buy	290,205 +158,685	+121%	+$17.8M	0.02%	561
2014 Q4	$14.7M	Buy	+131,520	New	+$11.7M	0.01%	647

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Janus Henderson Investors US's AGIO Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Agios Pharmaceuticals (AGIO) stake by 2.4% in Q1 2017, selling an estimated $440K and leaving 375,084 shares worth $21.9M. The position accounts for 0.02% of the portfolio, ranked #595.

Janus Henderson Investors US first reported a position in AGIO in Q4 2014 and has held it in 9 quarters since. The position peaked at $33.4M in Q2 2015. 156 funds tracked by Wall St. Rank hold AGIO as of Q1 2017.

Janus Henderson Investors US held 375,084 shares of Agios Pharmaceuticals worth $21.9M as of Q1 2017.
Janus Henderson Investors US sold 9,180 Agios Pharmaceuticals shares in Q1 2017, an estimated $440K.
Agios Pharmaceuticals made up 0.02% of Janus Henderson Investors US's portfolio in Q1 2017, its #595 holding.
Janus Henderson Investors US first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 9 quarters since.
Janus Henderson Investors US's Agios Pharmaceuticals position peaked at $33.4M in Q2 2015.
156 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.